VanEck Biotech ETF
BBH
83 hedge funds and large institutions have $67.8M invested in VanEck Biotech ETF in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 30 reducing their positions, and 8 closing their positions.
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
1% more funds holding
Funds holding: 82 → 83 (+1)
0.58% less ownership
Funds ownership: 16.92% → 16.34% (-0.58%)
9% less call options, than puts
Call options by funds: $1.27M | Put options by funds: $1.4M
10% less capital invested
Capital invested by funds: $75.4M → $67.8M (-$7.53M)
57% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Conservest Capital Advisors
Wynnewood,
Pennsylvania
|
+$1.18M |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$628K |
| 3 |
TC
Telemus Capital
Southfield,
Michigan
|
+$584K |
| 4 |
PA
PFG Advisors
Phoenix,
Arizona
|
+$265K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$246K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.58M |
| 2 |
Morgan Stanley
New York
|
-$1.89M |
| 3 |
VF
Virtu Financial
New York
|
-$1.37M |
| 4 |
Jane Street
New York
|
-$1.18M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$819K |
BBH Hedge Fund Activity: Q2 2018 in Review
83 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2018, worth a combined $67.8M — down 10% from $75.4M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BBH positions and 8 closed out — a net gain of 1 holder — while 13 added to existing stakes and 30 trimmed.
The largest buyer was Conservest Capital Advisors, opening a new position worth an estimated $1.18M. The largest seller was Susquehanna International Group, cutting an estimated $2.58M.
- 83 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2018, up from 82 in Q1 2018.
- Funds reported $67.8M of VanEck Biotech ETF stock for Q2 2018, down 10% quarter-over-quarter.
- 9 funds opened new VanEck Biotech ETF positions in Q2 2018 and 8 closed out, a net change of +1 holder.
- The largest VanEck Biotech ETF buyer in Q2 2018 was Conservest Capital Advisors, an estimated $1.18M added.
- The largest VanEck Biotech ETF seller in Q2 2018 was Susquehanna International Group, an estimated $2.58M sold.
Based on aggregated 13F filings for Q2 2018.